InterMune (ITMN +6.1%) rallies after Wells Fargo notes French regulators gave a favorable rating...

|By:, SA News Editor

InterMune (ITMN +6.1%) rallies after Wells Fargo notes French regulators gave a favorable rating to the company's Esbriet lung disease drug. Wells believes the rating should allow InterMune to "negotiate premium pricing" for Esbriet. (previously)